.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Queensland Health
Daiichi Sankyo
Chubb
Baxter
Citi
Healthtrust
McKesson
Julphar
Johnson and Johnson

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062774

« Back to Dashboard

NDA 062774 describes CEFADROXIL, which is a drug marketed by Aurobindo Pharma, Cspc Ouyi Pharm Co, Hikma, Ivax Sub Teva Pharms, Lupin, Orchid Hlthcare, Purepac Pharm, Ranbaxy Labs Ltd, Sandoz, Teva, Teva Pharms, Ani Pharms Inc, Apothecon, Aurobindo, Hikma Pharms, Sun Pharm Inds Ltd, and Ranbaxy, and is included in twenty-three NDAs. It is available from twenty-four suppliers. Additional details are available on the CEFADROXIL profile page.

The generic ingredient in CEFADROXIL is cefadroxil/cefadroxil hemihydrate. Twenty-four suppliers are listed for this compound. Additional details are available on the cefadroxil/cefadroxil hemihydrate profile page.

Summary for 062774

Tradename:1
Applicant:1
Ingredient:1
Patents:0

Pharmacology for NDA: 062774

Ingredient-typeCephalosporins

Suppliers and Packaging for NDA: 062774

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CEFADROXIL cefadroxil/cefadroxil hemihydrate TABLET;ORAL 062774 ANDA Teva Pharmaceuticals USA Inc 0093-4059 0093-4059-53 50 TABLET in 1 BOTTLE (0093-4059-53)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 1GM BASE
Approval Date:Apr 8, 1987TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Deloitte
Mallinckrodt
Merck
Medtronic
UBS
Covington
Argus Health
Harvard Business School
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot